Monday, September 29th, 2025

Singapore Construction Boom, Grab AV Launch, and Wilmar Verdict – Maybank Weekly Market Insights September 2025

Broker Name: Maybank Research Pte Ltd
Date of Report: 29 September 2025

Excerpt from Maybank Research Pte Ltd report.

Report Summary

  • Singapore is experiencing a significant construction boom driven by backlog in HDB and mega-projects, with expected real sector growth of over 5% annually from 2025-2030, well above GDP growth. This is expected to benefit banks (DBS, OCBC, UOB), contractors, real estate agents, and developers.
  • Grab announced the launch of Ai.R, Singapore’s first autonomous vehicle (AV) service, set to begin passenger operations in early 2026, potentially reducing costs and increasing productivity for Grab.
  • Singapore telco sector is showing signs of consolidation, with Starhub and Singtel expected to benefit despite some near-term headwinds such as the Optus outage.
  • Wilmar International faces near-term pressure after Indonesia’s Supreme Court overturned its acquittal in a cooking oil case, but liquidity concerns are mitigated as the fine was pre-emptively paid.
  • Marco Polo Marine is expanding its fleet, which could enhance earnings from FY27-30. Other trading ideas include Banyan Tree Holdings and NTT DC REIT.
  • SGX has launched new indices to increase visibility for mid-cap companies, and Nvidia is investing heavily in AI data center infrastructure in partnership with OpenAI.
  • Singapore’s inflation dipped in August, but 2026 CPI forecasts have been raised slightly. Analysts expect MAS to keep policy steady for the rest of 2025.

Above is an excerpt from a report by Maybank Research Pte Ltd. Clients of Maybank Research Pte Ltd can be the first to access the full report from the Maybank Research Pte Ltd website: https://www.maybank.com

Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals

Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals 🏢 Sino Biopharmaceutical (1177 HK) – Leading the Charge with Innovative Drug Development Recommendation: BUY Target Price: Not specified Stop Loss: Not...

“Navigating Market Volatility: Strategies for Investors in Turbulent Times”

OCBC Investment Research April 8, 2025 Navigating the Turbulent Tides: A Comprehensive Market Outlook United Overseas Bank Ltd (UOB SP) – Dividend and Buyback Support Amid Global Volatility Dividend and Buyback Provide Price Stability...

Vanzo Holdings Berhad’s RM21 Million ACE Market Debut: A Fresh Scent in Malaysia’s Air Fragrance Industry

Vanzo Holdings Berhad, a Malaysian air fragrance company, is set to list on the ACE Market of Bursa Malaysia on December 17, 2024. Below is a comprehensive overview of the IPO details: IPO Details:...